Clinical trial
Preservation of Beta-cell Function in Type 2 Diabetes Mellitus
NCT00232583 · University of Texas Southwestern Medical Center, Other · Completed
Key facts
| NCT number | NCT00232583 |
|---|---|
| Title | Preservation of Beta-cell Function in Type 2 Diabetes Mellitus |
| Official title | Preservation of Beta-cell Function in Type 2 Diabetes Mellitus |
| Lead sponsor | University of Texas Southwestern Medical Center, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Metformin, Insulin, Metfomin, Pioglitazone, glyburide |
| Enrollment | 58 |
| Start date | Nov 1, 2003 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Oct 4, 2005 |
| Last update posted | Dec 14, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: